Back to Search Start Over

MRD Status By Clonoseq ® Is a Poor Predictor of Long-Term Outcomes after Bispecific LV20.19 CAR T-Cell Therapy for Relapsed, Refractory B-Cell NHL

Authors :
Fateeha Furqan
Timothy S. Fenske
Walter L. Longo
Bryon Johnson
Mehdi Hamadani
Nirav N. Shah
Source :
Blood. 140:6407-6408
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Subjects

Subjects :
Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........2ed87000dafba53d10c8bccae66c4421
Full Text :
https://doi.org/10.1182/blood-2022-170047
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details